These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23392399)

  • 1. Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial.
    Muni RH; Kohly RP; Lee EQ; Manson JE; Semba RD; Schaumberg DA
    JAMA Ophthalmol; 2013 Apr; 131(4):514-21. PubMed ID: 23392399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship of Retinal Vessel Geometric Characteristics to the Incidence and Progression of Diabetic Retinopathy.
    Klein R; Lee KE; Danforth L; Tsai MY; Gangnon RE; Meuer SE; Wong TY; Cheung CY; Klein BEK
    Ophthalmology; 2018 Nov; 125(11):1784-1792. PubMed ID: 29779685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Hainsworth DP; Gao X; Bebu I; Das A; Olmos de Koo L; Barkmeier AJ; Tamborlane W; Lachin JM; Aiello LP;
    Ophthalmology; 2021 Apr; 128(4):554-560. PubMed ID: 32941962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy.
    Sasongko MB; Wong TY; Jenkins AJ; Nguyen TT; Shaw JE; Wang JJ
    Diabet Med; 2015 May; 32(5):686-91. PubMed ID: 25407692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes.
    Miljanovic B; Glynn RJ; Nathan DM; Manson JE; Schaumberg DA
    Diabetes; 2004 Nov; 53(11):2883-92. PubMed ID: 15504969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized Low-Density Lipoprotein and the Incidence of Proliferative Diabetic Retinopathy and Clinically Significant Macular Edema Determined From Fundus Photographs.
    Klein R; Myers CE; Lee KE; Paterson AD; Cruickshanks KJ; Tsai MY; Gangnon RE; Klein BE
    JAMA Ophthalmol; 2015 Sep; 133(9):1054-61. PubMed ID: 26181138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of serum lipid profile and other systemic risk factors with retinal hard exudates in diabetic retinopathy.
    Hiran HM; Kamath A; Mendonca TM; Rodrigues GR; Nayak RR; Kamath G; Kamath SJ
    Int Ophthalmol; 2024 Aug; 44(1):338. PubMed ID: 39095678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are soluble E-selectin, ICAM-1, and VCAM-1 potential predictors for the development of diabetic retinopathy in young adults, 15-34 years of age? A Swedish prospective cohort study.
    Ekelund C; Dereke J; Nilsson C; Landin-Olsson M
    PLoS One; 2024; 19(6):e0304173. PubMed ID: 38843125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes.
    Baker NL; Hunt KJ; Stevens DR; Jarai G; Rosen GD; Klein RL; Virella G; Lopes-Virella MF;
    Diabetes Care; 2018 Jan; 41(1):128-135. PubMed ID: 29118060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.
    Meigs JB; Hu FB; Rifai N; Manson JE
    JAMA; 2004 Apr; 291(16):1978-86. PubMed ID: 15113816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.
    ; Nathan DM; Bebu I; Hainsworth D; Klein R; Tamborlane W; Lorenzi G; Gubitosi-Klug R; Lachin JM
    N Engl J Med; 2017 Apr; 376(16):1507-1516. PubMed ID: 28423305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial.
    Lin J; Glynn RJ; Rifai N; Manson JE; Ridker PM; Nathan DM; Schaumberg DA
    Diabetes Care; 2008 Dec; 31(12):2338-43. PubMed ID: 18796620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological inflammatory factors as biomarkers for anatomic response in diabetic macular edema treated with anti-VEGF.
    Brito P; Costa J; Gomes N; Costa S; Correia-Pinto J; Silva R
    J Diabetes Complications; 2018 Jul; 32(7):643-649. PubMed ID: 29843962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.
    Seddon JM; George S; Rosner B; Rifai N
    Arch Ophthalmol; 2005 Jun; 123(6):774-82. PubMed ID: 15955978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in nonproliferative diabetic retinopathy.
    Haritoglou C; Kernt M; Neubauer A; Gerss J; Oliveira CM; Kampik A; Ulbig M
    Retina; 2014 Jan; 34(1):157-64. PubMed ID: 23792485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women.
    Schaumberg DA; Christen WG; Buring JE; Glynn RJ; Rifai N; Ridker PM
    Arch Ophthalmol; 2007 Mar; 125(3):300-5. PubMed ID: 17353399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethnic Differences in the Prevalence and Risk Factors of Diabetic Retinopathy: The Singapore Epidemiology of Eye Diseases Study.
    Tan GS; Gan A; Sabanayagam C; Tham YC; Neelam K; Mitchell P; Wang JJ; Lamoureux EL; Cheng CY; Wong TY
    Ophthalmology; 2018 Apr; 125(4):529-536. PubMed ID: 29217148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy.
    Klein BE; Knudtson MD; Tsai MY; Klein R
    Arch Ophthalmol; 2009 Sep; 127(9):1175-82. PubMed ID: 19752427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
    ; Gubitosi-Klug RA; Sun W; Cleary PA; Braffett BH; Aiello LP; Das A; Tamborlane W; Klein R
    JAMA Ophthalmol; 2016 Feb; 134(2):137-45. PubMed ID: 26584339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultra-Widefield and Early Treatment Diabetic Retinopathy Study 7-Field Grading of Diabetic Retinopathy.
    Aiello LP; Blodi B; Gao X; Sun JK; Gubitosi-Klug RA; White NH; Hainsworth D; Lorenzi GM; Bebu I;
    JAMA Ophthalmol; 2024 Sep; 142(9):856-863. PubMed ID: 39145984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.